Antibiotice SA has been one of the leading Romanian-owned manufacturers of generic drugs for over 67 years. European Investment Bank (EIB) advisory experts will focus on exploring different avenues for the company’s expansion, including portfolio repositioning, product label extension, the incorporation of new generics, and building new research and development facilities to create differentiated, high-value generic drugs.